Vitreous Tamponades Market Is Likely to Present an Opportunity Worth US $89.9 Mn by the End of 2025
Transparency Market Research (TMR) in a new market study reports that the global vitreous tamponades market is highly fragmented with the presence of small and medium sized players. A distinct feature of the market is that each region is dominated by a select number of players. For instance, The Vitreous Tamponades Market in North America is dominated by Novartis AG and Valeant Pharmaceuticals that hold more than 50% of market share. Likewise, the European market for vitreous tamponades is characterized...
View full press release